S05
DRUG RE-PROFILINGiEco-Pharmaj— Identification of New Applications of Existing Medicines—
S05-1
DRUG RE-PROFILING RESEARCH
S05-2
Eco-Pharma in the research of the functions of ATP receptors
S05-4
Clinical and experimental evidence suggesting the usefulness of pemirolast for prevention of hypersensitivity reactions to paclitaxel
S05-5
Availability of NMDA receptor antagonist as adjuvant analgesics and therapeutic drugs for drug dependence
S05-6
Multiple pharmacological actions of antitussives possessing GIRK channel blocking action in models of intractable brain diseases
S05-7
DRUG RE-PROFILING (discovery of new efficacy from the current drug)